Figure 5. Investigation of underlying mechanism regarding ERscore. (A) GO enrichment analysis of ERscore. (B) KEGG pathway analysis of ERscore. (C) Determination of oncogenic hallmark pathways in terms of the ERscore risk cohorts utilizing GSVA. (D) The GSEA outcomes for the hallmark pathways between the high- and low-risk patients. (E) Kaplan-Meier curve uncovered the BCRF survival in overlapping hallmark pathways between GSVA and GSEA.